These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 12753767)
41. Ternary systems of naproxen with hydroxypropyl-beta-cyclodextrin and aminoacids. Mura P; Maestrelli F; Cirri M Int J Pharm; 2003 Jul; 260(2):293-302. PubMed ID: 12842348 [TBL] [Abstract][Full Text] [Related]
42. Study on the inclusion complexes of cryptotanshinone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin. Li JF; Wei YX; Ding LH; Dong C Spectrochim Acta A Mol Biomol Spectrosc; 2003 Oct; 59(12):2759-66. PubMed ID: 14499836 [TBL] [Abstract][Full Text] [Related]
43. Comparative study of ibuproxam complexation with amorphous beta-cyclodextrin derivatives in solution and in the solid state. Mura P; Zerrouk N; Faucci M; Maestrelli F; Chemtob C Eur J Pharm Biopharm; 2002 Sep; 54(2):181-91. PubMed ID: 12191690 [TBL] [Abstract][Full Text] [Related]
44. [The study on the preparation and spectroscopic properties of hydroxypropyl-beta-cyclodextrin/glipizide inclusion complex]. Zhang YM; Li X; Sun CS; Chen CF Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Mar; 28(3):711-4. PubMed ID: 18536450 [TBL] [Abstract][Full Text] [Related]
45. Inclusion complex of ITH12674 with 2-hydroxypropyl-β-cyclodextrin: Preparation, physical characterization and pharmacological effect. Michalska P; Wojnicz A; Ruiz-Nuño A; Abril S; Buendia I; León R Carbohydr Polym; 2017 Feb; 157():94-104. PubMed ID: 27988012 [TBL] [Abstract][Full Text] [Related]
46. Preparation and characterization of the inclusion complex of furosemide with hydroxypropyl-beta-cyclodextrin. Vlachou M; Papaïoannou G J Biomater Appl; 2003 Jan; 17(3):197-206. PubMed ID: 12614084 [TBL] [Abstract][Full Text] [Related]
47. Complexation with tolbutamide modifies the physicochemical and tableting properties of hydroxypropyl-beta-cyclodextrin. Suihko E; Korhonen O; Järvinen T; Ketolainen J; Jarho P; Laine E; Paronen P Int J Pharm; 2001 Mar; 215(1-2):137-45. PubMed ID: 11250099 [TBL] [Abstract][Full Text] [Related]
48. Inclusion complexes of chlorzoxazone with β- and hydroxypropyl-β-cyclodextrin: Characterization, dissolution, and cytotoxicity. Tang P; Li S; Wang L; Yang H; Yan J; Li H Carbohydr Polym; 2015 Oct; 131():297-305. PubMed ID: 26256188 [TBL] [Abstract][Full Text] [Related]
49. In vitro and in vivo evaluation of an amylobarbitone/hydroxypropyl-beta-cyclodextrin complex prepared by a freeze-drying method. Fathy M; Sheha M Pharmazie; 2000 Jul; 55(7):513-7. PubMed ID: 10944779 [TBL] [Abstract][Full Text] [Related]
50. Development of carvedilol-cyclodextrin inclusion complexes using fluid-bed granulation: a novel solid-state complexation alternative with technological advantages. Alonso EC; Riccomini K; Silva LA; Galter D; Lima EM; Durig T; Taveira SF; Martins FT; Cunha-Filho MS; Marreto RN J Pharm Pharmacol; 2016 Oct; 68(10):1299-309. PubMed ID: 27465985 [TBL] [Abstract][Full Text] [Related]
51. Effect of the hydrophobic nature of triacetyl-beta-cyclodextrin on the complexation with nicardipine hydrochloride: physicochemical and dissolution properties of the kneaded and spray-dried complexes. Fernandes CM; Veiga FJ Chem Pharm Bull (Tokyo); 2002 Dec; 50(12):1597-602. PubMed ID: 12499598 [TBL] [Abstract][Full Text] [Related]
52. The effect of pH and triethanolamine on sulfisoxazole complexation with hydroxypropyl-beta-cyclodextrin. Gladys G; Claudia G; Marcela L Eur J Pharm Sci; 2003 Nov; 20(3):285-93. PubMed ID: 14592694 [TBL] [Abstract][Full Text] [Related]
53. Original research paper. A superior preparation method for daidzein-hydroxypropyl-β-cyclodextrin complexes with improved solubility and dissolution: Supercritical fluid process. Pan H; Wang HB; Yu YB; Cheng BC; Wang XY; Li Y Acta Pharm; 2017 Mar; 67(1):85-97. PubMed ID: 28231046 [TBL] [Abstract][Full Text] [Related]
54. Influence of cyclodextrin complexation on piroxicam gel formulations. Jug M; Bećirević-Laćan M; Kwokal A; Cetina-Cizmek B Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834 [TBL] [Abstract][Full Text] [Related]
55. Physico-chemical characterization and in vitro dissolution assessment of clonazepam-cyclodextrins inclusion compounds. Patel R; Purohit N AAPS PharmSciTech; 2009; 10(4):1301-12. PubMed ID: 19885735 [TBL] [Abstract][Full Text] [Related]
56. Inclusion complexation of nimesulide with beta-cyclodextrins. Vavia PR; Adhage NA Drug Dev Ind Pharm; 1999 Apr; 25(4):543-5. PubMed ID: 10194611 [TBL] [Abstract][Full Text] [Related]
57. Melatonin/HPβCD complex: Microwave synthesis, integration with chitosan scaffolds and inhibitory effects on MG-63CELLS. Topal B; Çetin Altındal D; Gümüşderelioğlu M Int J Pharm; 2015 Dec; 496(2):801-11. PubMed ID: 26602292 [TBL] [Abstract][Full Text] [Related]
58. Complexation of zolpidem with 2-hydroxypropyl-beta-, methyl-beta-, and 2-hydroxypropyl-gamma-cyclodextrin: effect on aqueous solubility, dissolution rate, and ataxic activity in rat. Trapani G; Latrofa A; Franco M; Pantaleo MR; Sanna E; Massa F; Tuveri F; Liso G J Pharm Sci; 2000 Nov; 89(11):1443-51. PubMed ID: 11015689 [TBL] [Abstract][Full Text] [Related]
59. Solid state characterization of progesterone in a freeze dried 1:2 progesterone/HPBCD mixture. Zoppetti G; Puppini N; Ospitali F; Fini A J Pharm Sci; 2007 Jul; 96(7):1729-36. PubMed ID: 17514727 [TBL] [Abstract][Full Text] [Related]
60. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]